ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 65 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 582 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 582 | -7.9% | 0.00% | – |
| Q2 2018 | $1,000 | -85.7% | 632 | -85.7% | 0.00% | – |
| Q1 2018 | $7,000 | -12.5% | 4,424 | +23.6% | 0.00% | – |
| Q4 2017 | $8,000 | +300.0% | 3,578 | +433.2% | 0.00% | – |
| Q3 2017 | $2,000 | -33.3% | 671 | -11.7% | 0.00% | – |
| Q2 2017 | $3,000 | 0.0% | 760 | -6.2% | 0.00% | – |
| Q1 2017 | $3,000 | -97.2% | 810 | -96.5% | 0.00% | – |
| Q4 2016 | $108,000 | +980.0% | 23,409 | +858.2% | 0.00% | – |
| Q3 2016 | $10,000 | +66.7% | 2,443 | -14.8% | 0.00% | – |
| Q2 2016 | $6,000 | -87.5% | 2,868 | -72.3% | 0.00% | – |
| Q1 2016 | $48,000 | +152.6% | 10,369 | +114.1% | 0.00% | – |
| Q4 2015 | $19,000 | +171.4% | 4,842 | +187.5% | 0.00% | – |
| Q3 2015 | $7,000 | -93.9% | 1,684 | -93.3% | 0.00% | – |
| Q2 2015 | $114,000 | +1800.0% | 24,986 | +2924.9% | 0.00% | – |
| Q1 2015 | $6,000 | +200.0% | 826 | +9.8% | 0.00% | – |
| Q4 2014 | $2,000 | – | 752 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,699,848 | $15,687,000 | 2.68% |
| Northeast Financial Consultants Inc | 732,265 | $3,105,000 | 1.31% |
| WEDBUSH SECURITIES INC | 15,000 | $64,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 148,054 | $628,000 | 0.01% |
| THRIVENT FINANCIAL FOR LUTHERANS | 413,278 | $1,752,000 | 0.01% |
| Virtu KCG Holdings LLC | 72,989 | $309,000 | 0.01% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 35,555 | $151,000 | 0.00% |
| WILLIAMS JONES & ASSOCIATES LLC | 15,100 | $64,000 | 0.00% |
| BlackRock Fund Advisors | 612,231 | $2,596,000 | 0.00% |
| Spot Trading L.L.C | 15,000 | $64,000 | 0.00% |